Impax Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Impax Asset Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-167,074	Closed	-$8.97M	–	202
2015 Q2	$8.97M	Buy	167,074 +21,881	+15%	+$1.06M	0.48%	77
2015 Q1	$6.9M	Buy	145,193 +32,031	+28%	+$1.42M	0.38%	83
2014 Q4	$4.89M	Buy	113,162 +71,031	+169%	+$2.9M	0.29%	76
2014 Q3	$1.45M	Buy	42,131 +15,000	+55%	+$530K	0.09%	144
2014 Q2	$994K	Buy	27,131 +8,875	+49%	+$301K	0.06%	162
2014 Q1	$616K	Buy	+18,256	New	+$602K	0.04%	176
2013 Q4	–	Sell	-14,000	Closed	-$446K	–	213
2013 Q3	$446K	Buy	+14,000	New	+$372K	0.03%	174

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Impax Asset Management's CMD Position: Q3 2015 in Review

Impax Asset Management sold out of Cantel Medical Corporation (CMD) in Q3 2015, closing a stake of 167,074 shares — an estimated $8.97M sold.

Impax Asset Management first reported a position in CMD in Q3 2013 and held it in 7 quarters. The position peaked at $8.97M in Q2 2015. 172 funds tracked by Wall St. Rank hold CMD as of Q3 2015.

Impax Asset Management reported no remaining Cantel Medical Corporation position as of Q3 2015 after selling out during the quarter.
Impax Asset Management sold 167,074 Cantel Medical Corporation shares in Q3 2015, an estimated $8.97M.
Impax Asset Management first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 7 quarters.
Impax Asset Management's Cantel Medical Corporation position peaked at $8.97M in Q2 2015.
172 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2015.

Based on Impax Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.